1,516 articles
Stephen B. Hulley
Stephen B. Hulley, also known as Stephen Hulley, was an American physician-scientist at UCSF who led the HERS hormone therapy trial and wrote Designing Clinical Research.
Stephen D. Wiviott
Stephen D. Wiviott is an American cardiologist and Harvard Medical School professor who led the TRITON-TIMI 38 and DECLARE-TIMI 58 trials at Brigham and Women's Hospital.
Stephen F. Vatner
Stephen F. Vatner is an American cardiovascular physiologist who argued in 1975 for studying conscious animals, helped discover myocardial stunning, and chaired cell biology at Rutgers New Jersey Medical School.
Stephen G. Ellis
Stephen G. Ellis is an American interventional cardiologist who directs interventional cardiology at Cleveland Clinic and led randomized coronary stent trials including FINESSE and ABSORB III.
Stephen G. Young
Stephen G. Young (born 1952) is an American physician-scientist at UCLA whose research covers triglyceride metabolism and nuclear envelope diseases, including his discovery of the endothelial protein GPIHBP1.
Stephen J. Marx
Stephen J. Marx is an American endocrinologist at the NIH's NIDDK who spent over twenty years treating MEN1 patients and helped positionally clone the MEN1 gene in 1997.
Stephen J. Nicholls
Stephen J. Nicholls is an Australian preventive cardiologist who directs the Victorian Heart Institute and Victorian Heart Hospital and is Professor of Cardiology at Monash University.
Stephen M. Prescott
Stephen M. Prescott (1948–2021) was an American physician-scientist and lipid biochemist whose COX-2 research contributed to arthritis drugs; he led Utah's Huntsman Cancer Institute and the Oklahoma Medical Research Foundation.
Stephen MacMahon
Stephen MacMahon (S MacMahon) is an Australian cardiovascular physician-scientist and epidemiologist known for large-scale blood pressure studies and for co-founding The George Institute in Sydney in 1999.
Steve E. Humphries
Steve E. Humphries is a British cardiovascular geneticist who was British Heart Foundation Professor at University College London from 1991 to 2015, known for work on familial hypercholesterolaemia genetics.
Steve R. Ommen
Steve R. Ommen is an American cardiologist at Mayo Clinic who directs its Hypertrophic Cardiomyopathy Clinic and chaired the 2020 AHA/ACC guideline for the condition.
Steven A. Kliewer
Steven A. Kliewer is an American molecular biologist and pharmacologist at UT Southwestern Medical Center in Dallas, known for defining targets of thiazolidinedione diabetes drugs and discovering FGF19 and FGF21.
Steven B. Heymsfield
Steven B. Heymsfield, born 1944 in Brooklyn, is an American physician-scientist studying obesity and body composition at Pennington Biomedical Research Center, named an LSU Boyd Professor in 2025.
Steven E. Kahn
Steven E. Kahn is a physician-scientist in endocrinology at the University of Washington and VA Puget Sound, known for major type 2 diabetes trials and beta-cell research.
Steven E. Nissen
Steven E. Nissen is an American cardiologist at the Cleveland Clinic who pioneered intravascular ultrasound imaging of coronary arteries and led trials linking Vioxx and rosiglitazone to heart risk.
Steven E. Shoelson
Steven E. Shoelson is an American physician-scientist at Joslin Diabetes Center and Harvard Medical School known for identifying inflammation as a mediator of insulin resistance in type 2 diabetes.
Steven Grinspoon
Steven K. Grinspoon is an American endocrinologist and Harvard Medical School professor who studies metabolism in people with HIV, developed tesamorelin, and led the REPRIEVE statin trial.
Steven M. Haffner
Steven M. Haffner is an American endocrinologist and diabetes epidemiologist at the University of Texas Health Science Center in San Antonio, known for the San Antonio Heart Study.
Steven O. Marx
Steven O. Marx is an American cardiac electrophysiologist at Columbia University who studies ion channel regulation in arrhythmias and heart failure, and directs its cardiovascular fellowship program.
Steven W. J. Lamberts
Steven W. J. Lamberts, born 1944, is a Dutch endocrinologist at Erasmus Medical Center in Rotterdam, known for introducing long-acting somatostatin analog therapy for acromegaly.
Stevo Julius
Stevo Julius (1929–2025) was a Croatian-born American physician-scientist who spent six decades at the University of Michigan, known for defining borderline hypertension and leading major hypertension trials.
Stuart J. Connolly
Stuart J. Connolly (1949–2024) was a Canadian cardiologist and clinical trialist at McMaster University in Hamilton, Ontario, known for trials that reshaped stroke prevention in atrial fibrillation.
Stuart Rich
Stuart Rich is an American cardiologist and Professor Emeritus of Medicine at Northwestern University whose career has focused on pulmonary hypertension, leading the NIH registry and pioneering epoprostenol therapy.
Subodh Verma
Subodh Verma is a Canadian cardiac surgeon-scientist at St. Michael's Hospital in Toronto and a University of Toronto professor known for leadership in global heart failure and semaglutide trials.
Sunao Tawara
Sunao Tawara (田原淳), 1873 to 1952, was a Japanese pathologist at Kyushu University who discovered the AV node and mapped the heart's conduction system in his 1906 monograph.
Susan Bonner‐Weir
Susan Bonner-Weir is a diabetes researcher, Senior Investigator at Joslin Diabetes Center and Professor of Medicine at Harvard Medical School, known for work on beta-cell regeneration and beta-cell senescence.
Susanna C. Larsson
Susanna C. Larsson, also published as Susanna Larsson, is a Swedish nutritional and cardiovascular epidemiologist and professor at Karolinska Institutet known for large cohort studies of diet and disease risk.
Susumu Seino
Susumu Seino (清野 進, 1948–2021) was a Japanese molecular physiologist at Kobe University who defined the β-cell KATP channel and discovered Epac2, winning the 2018 Japan Academy Prize.
Suzanne Oparil
Suzanne Oparil is an American cardiologist and hypertension researcher at the University of Alabama at Birmingham who led the UAB center of the SPRINT blood-pressure trial.
Takashi Kadowaki
Takashi Kadowaki (門脇孝) is a Japanese diabetes researcher and president of Toranomon Hospital, known for discovering the adiponectin receptors and winning the 2013 Japan Academy Prize.